SARS-CoV-2 vaccination predicts COVID-19 progression and outcomes in hospitalized patients
Abstract
Background
SARS-CoV-2 vaccination might impact on clinical progression of cases with breakthrough COVID-19 disease.
Objective
to evaluate the impact of SARS-CoV-2 vaccination on disease progression in COVID-19 hospitalized patient
Methods and Findings
Two-hundred eighty-four consecutive COVID-19 hospitalized patients, including 50 vaccinated cases entered the study. Compared to unvaccinated cases, vaccinated patients were older, exhibited more comorbidities and did not differ for COVID-19 severity at admission. During hospitalisation, unvaccinated patients showed worse disease progression, including higher need of oxygen and higher risk of death compared to vaccinated patients (OR 3.3; 1.05-10.7 95% CI in the whole cohort and OR 54.8; 3.5-852 in the ventilated cases).
Discussion
These findings argue for an important reduction in severity among vaccine breakthrough infection compared to unvaccinated cases in COVID-19 disease.
Related articles
Related articles are currently not available for this article.